ABBV
AbbVie Inc.
Stock
$266.28+1.94 (+0.73%)Close Sep 28, 2026
ABBV's gross profit for 2025 was $42.96 billion, up 8.9% from the year before.
From SEC filings, Latest filing: 10-Q, Aug 3, 2026
| Gross profit (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $46.02B | +11.2% | 7.1% | 8.9% |
| Gross profit (TTM) | $46.02B |
|---|---|
| YoY | +11.2% |
| 5-year CAGR | 7.1% |
| 10-year CAGR | 8.9% |
Gross profit
| Period | Gross profit | YoY |
|---|---|---|
| 2025 | $43.0B | +8.9% |
| 2024 | $39.4B | +16.3% |
| 2023 | $33.9B | −16.6% |
| 2022 | $40.6B | +4.9% |
| 2021 | $38.8B | +27.4% |
| 2020 | $30.4B | +17.8% |
| 2019 | $25.8B | +3.2% |
| 2018 | $25.0B | +18.2% |
| 2017 | $21.2B | +6.9% |
| 2016 | $19.8B | +7.9% |
| 2015 | $18.4B | +18.2% |
| 2014 | $15.5B | +9.3% |
| 2013 | $14.2B | +2.4% |
| 2012 | $13.9B | +8.3% |
| 2011 | $12.8B | — |